Neuropsychiatric co-morbidities in non-demented Parkinson's disease

Annals of Indian Academy of Neurology

Volumn 18, Issue 1, 2015, Pages 33-38

  Rai, Nirendra ^a   Goyal, Vinay ^a   Kumar, Nand ^a   Shukla, Garima ^a   Srivastava, Achal ^a   Singh, Sumit ^b   Behari, Madhuri ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b Departments of Neurology All India Institute of Medical Sciences ^*  (India)

Author keywords

Anxiety; comorbidity; depression; neuropsychiatry; Parkinson's disease; psychosis

Indexed keywords

ADULT; AGE; ANXIETY DISORDER; ARTICLE; AUDITORY HALLUCINATION; BECK DEPRESSION INVENTORY; BRIEF PSYCHIATRIC RATING SCALE; CLINICAL FEATURE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DELUSION; DEPRESSION; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; DISEASE SEVERITY; FALLING; FEMALE; GENERAL MENTAL DISEASE ASSESSMENT; HAMILTON ANXIETY SCALE; HOEHN AND YAHR SCALE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; MINI MENTAL STATE EXAMINATION; MORTALITY; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE ASSESSMENT; NEUROPSYCHIATRY; OLFACTORY HALLUCINATION; ONSET AGE; PARKINSON DISEASE; PREVALENCE; PSYCHOSIS; RECEIVER OPERATING CHARACTERISTIC; SCHWAB AND ENGLAND SCALE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SUICIDE ATTEMPT; UNIFIED PARKINSON DISEASE RATING SCALE; VISUAL HALLUCINATION;

EID: 84923037727     PISSN: 09722327     EISSN: 19983549     Source Type: Journal    
DOI: 10.4103/0972-2327.144287     Document Type: Article

References (49)

1. Aarsland D, Larsen JP, Lim NG, Janvin C, Karlsen K, Tandberg E, et al. Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999;67: 492-6.
2. Brown RG, MacCarthy B. Psychiatric morbidity in patients with Parkinson's disease. Psychol Med 1990;20:77-87.
3. Karlsen KH, Tandberg E, Arsland D, Larsen JP. Health related quality of life in Parkinson's disease: A prospective longitudinal study. J Neurol Neurosurg Psychiatry 2000;69:584-9.
4. Behari M, Srivastava AK, Pandey RM. Quality of life in patients with Parkinson's disease. Parkinsonism Relat Disord 2005;11:221-6.
5. Aarsland D, Larsen JP, Larsen JP. Mental symptoms in Parkinson's disease are important contributors to caregiver distress. Int J Geriatr Psychiatry 1999;14:866-74.
6. Aarsland D, Larsen JP, Tandberg E, Laake K. Predictors of nursing home placement in Parkinson's disease: A population-based, prospective study. J Am Geriatr Soc 2000;48:938-42.
7. Goetz CG, Stebbins GT. Mortality and hallucinations in nursing home patients with advanced Parkinson's disease. Neurology 1995;45:669-71.
8. Kulisevsky J, Pagonabarraga J, Pascual-Sedano B, Garciá-Sánchez C, Gironell A. Trapecio Group Study. Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia. Mov Disord 2008;23:1889-96.
9. Nuti A, Ceravolo R, Piccinni A, Dell'Agnello G, Bellini G, Gambaccini G, et al. Psychiatric comorbidity in a population of Parkinson's disease patients. Eur J Neurol 2004;11:315-20.
10. Holroyd S, Currie L, Wooten GF. Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001;70:734-8.
11. Goetz CG, Leurgans S, Pappert EJ, Raman R, Stemer AB. Prospective longitudinal assessment of hallucinations in Parkinson's disease. Neurology 2001;57:2078-82.
12. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 2001;57:1497-9.
13. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 4 th ed. Washington; 1994.
14. Lim SY, Evans AH, Miyasaki JM. Impulse control and related disorders in Parkinson's disease: Review. Ann N Y Acad Sci 2008;1142:85-107.
15. Fahn S, Elton RL. Members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, M Goldstein, editors. Recent Development in Parkinson's Disease. Florham Park: Macmillan Health Care Information; 1987. p. 153-63.
16. Hoehn MH, Yahr MD. Parkinsonism: Onset, progression, and mortality. Neurology 1967;17:427-42.
17. Schwab JF, England AC. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham FJ, Donaldson MC, editors. Third Symposium on Parkinson's Disease; 1968; Edinburgh, UK. E & S Livingston; 1969. p. 152-7.
18. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl 20):22-33.
19. Dissanayaka NN, Sellbach A, Matheson S, O'Sullivan JD, Silburn PA, Byrne GJ, et al. Anxiety disorders in Parkinson's disease: Prevalence and risk factors. Mov Disord 2010;25:838-45.
20. Schneider CB, Pilhatsch M, Rifati M, Jost WH, Wodarz F, Ebersbach G, et al. Utility of the WHO-Five wellbeing index as a screening tool for depression in Parkinson's disease. Mov Disord 2010;25:777-83.
21. Leentjens AF, Verhey FR, Luijckx GJ, Troost J. The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease. Mov Disord 2000;15:1221-4.
22. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:790-812.
23. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-5.
24. Berrios GE, Campbell C, Politynska BE. Autonomic failure, depression and anxiety in Parkinson's disease. Br J Psychiatry 1995;166:789-92.
25. Cummings JL. Depression and Parkinson's disease: A review. Am J Psychiatry 1992;149:443-54.
26. Sano M, Stern Y, Williams J, Cote L, Rosenstein R, Mayeux R. Coexisting dementia and depression in Parkinson's disease. Arch Neurol 1989;46:1284-6.
27. Ravina B, Camicioli R, Como PG, Marsh L, Jankovic J, Weintraub D, et al. The impact of depressive symptoms in early Parkinson disease. Neurology 2007;69:342-7.
28. Dooneief G, Mirabello E, Bell K, Marder K, Stern Y, Mayeux R. An estimate of incidence of depression in idiopathic Parkinson's disease. Arch Neurol 1992;49:305-7.
29. Zesiewicz TA, Gold M, Chari G, Hauser RA. Current issues in depression in Parkinson's disease. Am J Geriatr Psychiatry 1999;7:110-8.
30. Cummings JL, Masterman DL. Depression in patients with Parkinson's disease. Int J Geriatr Psychiatry 1999;14:711-8.
31. Gotham AM, Brown RG, Marsden CD. Depression in Parkinson's disease: A quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 1986;49:381-9.
32. Starkstein SE, Preziosi TJ, Bolduc PL, Robinson RG. Depression in Parkinson's disease. J Nerv Ment Dis 1990;178:27-31.
33. Remy P, Doder M, Lees A, Turjanski N, Brooks D. Depression in Parkinson's disease: Loss of dopamine and noradrenaline innervations in limbic system. Brain 2005;128:1314-22.
34. Miguelez C, Grandoso L, Ugedo L. Locus coeruleus and dorsal raphe neuron activity and response to acute antidepressant administration in a rat model of Parkinson's disease. Int J Neuropsychopharmacol 2011;14:187-200.
35. Fukunishi I, Hosokawa K, Ozaki S. Depression antedating onset of Parkinson's disease. Jpn J Psychiatry Neurol 1991;45:7-11.
36. Shiba M, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: A case-control study. Mov Disord 2000;15:669-77.
37. Nazem S, Siderowf AD, Duda JE, Brown GK, Ten Have T, Stern MB, et al. Suicidal and death ideation in Parkinson's disease. Mov Disord 2008;23:1573-9.
38. Papapetropoulos S, Mash DC. Psychotic symptoms in Parkinson's disease. From description to etiology. J Neurol 2005;252:753-64.
39. Fénelon G, Goetz CG, Karenberg A. Hallucinations in Parkinson disease in the prelevodopa era. Neurology 2006;66:93-8.
40. Diederich NJ, Goetz CG, Stebbins GT. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: Focused review and a new integrative model. Mov Disord 2005;20:130-40.
41. Graham JM, Grunewald RA, Sagar HJ. Hallucinations in idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;63: 434-40.
42. Goetz CG, Pappert EJ, Blasucci LM. Intravenous levodopa in chronically treated hallucinating Parkinson's patients: High dose pharmacological challenge does not precipitate visual hallucinations. Neurology 1998;50:515-7.
43. Fénelon G, Soulas T, Zenasni F, Cleret de Langavan L. The changing face of Parkinson's disease-associated psychosis: A cross-sectional study based on the new NINDS-NIMH criteria. Mov Disord 2010;25:763-6.
44. Chen JJ. Anxiety, depression, and psychosis in Parkinson's disease: Unmet needs and treatment challenges. Neurol Clin 2004;22:S63-90.
45. Menza MA, Robertson-Hoffman DE, Bonapace AS. Parkinson's disease and anxiety: Comorbidity with depression. Biol Psychiatry 1993;34:465-70.
46. Witjas T, Kaphan E, Azulay JP, Blin O, Ceccaldi M, Pouget J, et al. Nonmotor fluctuations in Parkinson's disease: Frequent and disabling. Neurology 2002;59:408-13.
47. Schiffer RB, Kurlan R, Rubin A, Boer S. Evidence for atypical depression in Parkinson's disease. Am J Psychiatry 1988;145:1020-2.
48. Byers AL, Yaffe K, Covinsky KE, Friedman MB, Bruce ML. High occurrence of mood and anxiety disorders among older adults: The National Comorbidity Survey Replication. Arch Gen Psychiatry 2010;67:489-96.
49. Stein MB, Heuser IJ, Juncos JL, Uhde TW. Anxiety disorder in patients with Parkinson's disease. Am J Psychiatry 1990;147: 217-20.